Paper41301427
Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines.
Kohm E and 2 others. Biomolecules, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines. Papers, record 41301427. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301427
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptors, Mineralocorticoid | Major topic |
| Glucuronidase | Major topic |
| Signal Transduction | Major topic |
| Kidney | Major topic |
| Klotho Proteins | |
| Animals | |
| Dogs | |
| Humans | |
| Rats | |
| Mineralocorticoid Receptor Antagonists | |
| Cell Line | |
| Madin Darby Canine Kidney Cells | |
| Aldosterone | |
| Spironolactone | |
| Gene Expression Regulation | |
| Eplerenone |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 695/2-2. | Deutsche Forschungsgemeinschaft | PubMed |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30469400 | Long-Term Effects of Spironolactone on Kidney Function and Hyperkalemia-Associated Hospitalization in Patients with Chronic Kidney Disease. | J Clin Med | 2018 | https://conductscience.org/library/papers/30469400 | PubMed |
| 2 | 31199502 | Regulation of fibroblast growth factor 23 (FGF23) in health and disease. | FEBS Lett | 2019 | https://conductscience.org/library/papers/31199502 | PubMed |
| 3 | 3485096 | The synthesis of aldosterone by the adrenal cortex. Two zones (fasciculata and glomerulosa) possess one enzyme for 11 beta-, 18-hydroxylation, and aldehyde synthesis. | J Biol Chem | 1986 | https://conductscience.org/library/papers/3485096 | PubMed |
| 4 | 39349629 | Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial. | Nat Med | 2024 | https://conductscience.org/library/papers/39349629 | PubMed |
| 5 | 19617444 | The mineralocorticoid receptor and its coregulators. | J Mol Endocrinol | 2009 | https://conductscience.org/library/papers/19617444 | PubMed |
| 6 | 34461222 | Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders - New perspectives for combination therapy. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/34461222 | PubMed |
| 7 | 2357784 | Use of spironolactone in treatment of hirsutism. | Cleve Clin J Med | 1990 | https://conductscience.org/library/papers/2357784 | PubMed |
| 8 | 9360552 | Colocalization of 11 beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. | J Clin Endocrinol Metab | 1997 | https://conductscience.org/library/papers/9360552 | PubMed |
| 9 | 39225278 | Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. | N Engl J Med | 2024 | https://conductscience.org/library/papers/39225278 | PubMed |
| 10 | 25376771 | On the pleotropic actions of mineralocorticoids. | Nephron Physiol | 2014 | https://conductscience.org/library/papers/25376771 | PubMed |
| 11 | 166833 | Antiandrogenic effect of spirolactones: mechanism of action. | Endocrinology | 1975 | https://conductscience.org/library/papers/166833 | PubMed |
| 12 | 38947237 | The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38947237 | PubMed |
| 13 | 34514191 | Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease. | Kidney Int Rep | 2021 | https://conductscience.org/library/papers/34514191 | PubMed |
| 14 | 22012806 | Regulation of epithelial Na+ channels by adrenal steroids: mineralocorticoid and glucocorticoid effects. | Am J Physiol Renal Physiol | 2012 | https://conductscience.org/library/papers/22012806 | PubMed |
| 15 | 8421998 | Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. | Am J Cardiol | 1993 | https://conductscience.org/library/papers/8421998 | PubMed |
| 16 | 20331602 | Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20331602 | PubMed |
| 17 | 38729987 | Klotho is highly expressed in the chief sites of regulated potassium secretion, and it is stimulated by potassium intake. | Sci Rep | 2024 | https://conductscience.org/library/papers/38729987 | PubMed |
| 18 | 10471456 | The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10471456 | PubMed |
| 19 | 33153631 | Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart Failure. | Mayo Clin Proc | 2020 | https://conductscience.org/library/papers/33153631 | PubMed |
| 20 | 3208966 | Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist. | Eur J Obstet Gynecol Reprod Biol | 1988 | https://conductscience.org/library/papers/3208966 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42469710 | Non-steroidal mineralocorticoid receptor antagonists in non-diabetic kidney disease: a narrative review of mechanisms and clinical advances. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42469710 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41301427
GET https://conductscience.org/api/papers/v1/41301427/references?page=2